ES2123775T3 - Procedimiento para la tipificacion de hla-b por medio de iniciadores especificos y conjuntos de sondas. - Google Patents

Procedimiento para la tipificacion de hla-b por medio de iniciadores especificos y conjuntos de sondas.

Info

Publication number
ES2123775T3
ES2123775T3 ES94909931T ES94909931T ES2123775T3 ES 2123775 T3 ES2123775 T3 ES 2123775T3 ES 94909931 T ES94909931 T ES 94909931T ES 94909931 T ES94909931 T ES 94909931T ES 2123775 T3 ES2123775 T3 ES 2123775T3
Authority
ES
Spain
Prior art keywords
hla
pct
alleles
appropriate
zemmour
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94909931T
Other languages
English (en)
Other versions
ES2123775T5 (es
Inventor
Marc Andrien
Etienne Dupont
Rudi Rossau
Canck Ilse De
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujirebio Europe NV SA
Original Assignee
Innogenetics NV SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8214689&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2123775(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Innogenetics NV SA filed Critical Innogenetics NV SA
Application granted granted Critical
Publication of ES2123775T3 publication Critical patent/ES2123775T3/es
Publication of ES2123775T5 publication Critical patent/ES2123775T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Inks, Pencil-Leads, Or Crayons (AREA)
  • Saccharide Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A UN METODO PARA TIPIFICAR O SUBTIPIFICAR HLA-B QUE SE CARACTERIZA POR LA SECUENCIA GCCA EN LA POSICION 30 A 33 DE EXON 2 (CON DICHA NUMERACION ESTANDO DE ACUERDO CON ZEMMOUR Y PARHAM, 1992), SUJETO A ESTAR PRESENTE EN UNA MUESTRA, CON DICHO METODO QUE COMPRENDE AL MENOS LOS SIGUIENTES PASOS: I) AMPLIFICAR EL HLA-B CON AL MENOS UN ELEMENTO PRIMARIO DE AMPLIFICACION DEL EXTREMO 5'' DE LA SIGUIENTE LISTA: 5''-AGGTATTTCTACCCGCCA-3'' (B25P) O VARIANTES DE LA SECUENCIA DEL MISMO, EN COMBINACION CON UN ELEMENTO FUNDAMENTAL DEL EXTREMO 3'' APROPIADO ESCOGIDO ENTRE LOS MISMOS QUE LOS ELEMENTOS FUNDAMENTALES ANTES DEFINIDOS DEL EXTREMO 5'', ESTANDO POSIBLEMENTE ETIQUETADOS LOS ELEMENTOS FUNDAMENTALES DE LOS EXTREMOS 5'' Y 3''; II) HIBRIDIZAR EL PRODUCTO AMPLIFICADO, SIENDO ETIQUETADO DURANTE O DESPUES DE LA AMPLIFICACION, EN CONDICIONES APROPIADAS CON UNA O MAS SONDAS ADECUADAS SELECCIONADAS ENTRE LA REGION 15 A 261 DE LA REGION EXON 2 DEL HLA-B, ESTANDO DICHA NUMERACION DE ACUERDOCON ZEMMOUR Y PARHAM, 1992, III) LAVAR EN CONDICIONES DE LAVADO APROPIADAS; IV) DETECTAR LOS HIBRIDOS FORMADOS; Y V) INGERIR EL HLA-B PRESENTA A PARTIR DEL MODELO DE HIBRIDIZACION OBSERVADO.
ES94909931T 1993-03-18 1994-03-07 Procedimiento para la tipificacion de hla-b por medio de iniciadores especificos y conjuntos de sondas. Expired - Lifetime ES2123775T5 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP93400700 1993-03-18
EP93400700 1993-03-18

Publications (2)

Publication Number Publication Date
ES2123775T3 true ES2123775T3 (es) 1999-01-16
ES2123775T5 ES2123775T5 (es) 2005-10-01

Family

ID=8214689

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94909931T Expired - Lifetime ES2123775T5 (es) 1993-03-18 1994-03-07 Procedimiento para la tipificacion de hla-b por medio de iniciadores especificos y conjuntos de sondas.

Country Status (10)

Country Link
US (1) US5883238A (es)
EP (1) EP0689609B2 (es)
JP (1) JP4031028B2 (es)
AT (1) ATE169682T1 (es)
AU (1) AU688307B2 (es)
CA (1) CA2158578C (es)
DE (1) DE69412470T3 (es)
DK (1) DK0689609T4 (es)
ES (1) ES2123775T5 (es)
WO (1) WO1994021818A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5550039A (en) * 1995-03-07 1996-08-27 Hoffmann-La Roche Inc. Oligonucleotide primers for HLA class I B locus DNA typing
ATE197481T1 (de) * 1996-02-20 2000-11-11 Perkin Elmer Corp Verfahren und reagenzien zur typisierung von hla- genen der klasse i
EP0953650A1 (en) * 1998-04-20 1999-11-03 Innogenetics N.V. Method for typing of HLA alleles
US6436642B1 (en) 1999-04-20 2002-08-20 Curagen Corporation Method of classifying a thyroid carcinoma using differential gene expression
AU5062500A (en) * 1999-04-26 2000-11-10 Amersham Pharmacia Biotech Ab Primers for identifying typing or classifying nucleic acids
CA2413931A1 (en) * 2000-06-01 2003-11-28 Nisshinbo Industries, Inc. Kit and method for determining hla types
US7943309B2 (en) * 2006-05-11 2011-05-17 Pharmigene Inc. HLA alleles associated with adverse drug reactions and methods for detecting such
WO2010151599A1 (en) * 2009-06-23 2010-12-29 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Human leukocyte antigen alleles associated with advanced lung diseases
WO2011130152A2 (en) 2010-04-12 2011-10-20 Academia Sinica Method for identifying hla complexes associated with adverse drug reactions
KR102131293B1 (ko) * 2018-06-29 2020-07-07 경북대학교 산학협력단 서열-특이적 올리고뉴클레오티드 프로브 방법에 의한 인간백혈구항원 형별 검사에서 인간백혈구항원의 최종 형별 판정 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4835098A (en) * 1985-09-04 1989-05-30 Regents Of University Of Minnesota Characterization of HLA alleles with locus-specific DNA probes
JPH0249589A (ja) * 1988-08-11 1990-02-19 Olympus Optical Co Ltd Hlaクラスidnaおよびdnaプローブ並びに形質転換細胞
IL113261A (en) 1989-09-01 1996-10-16 Hutchinson Fred Cancer Res Inhibition by peptides of lymphocyte adherence to vascular endothelium utilizing an extracellular matrix receptor-ligand interaction and pharmaceutical compositions containing said peptides
GB9002625D0 (en) * 1990-02-06 1990-04-04 Univ Singapore Human leukocyte antigen typing
GB9024005D0 (en) * 1990-11-05 1990-12-19 British Bio Technology Process for amplifying nucleic acid
EP0540997A1 (en) * 1991-11-05 1993-05-12 F. Hoffmann-La Roche Ag Methods and reagents for HLA class I DNA typing
US5550039A (en) * 1995-03-07 1996-08-27 Hoffmann-La Roche Inc. Oligonucleotide primers for HLA class I B locus DNA typing

Also Published As

Publication number Publication date
JPH08507690A (ja) 1996-08-20
DE69412470T2 (de) 1999-03-25
EP0689609B1 (en) 1998-08-12
US5883238A (en) 1999-03-16
EP0689609A1 (en) 1996-01-03
EP0689609B2 (en) 2005-04-13
DE69412470T3 (de) 2006-07-20
AU6258594A (en) 1994-10-11
CA2158578A1 (en) 1994-09-29
DK0689609T4 (da) 2005-07-25
WO1994021818A1 (en) 1994-09-29
CA2158578C (en) 2009-05-26
JP4031028B2 (ja) 2008-01-09
ATE169682T1 (de) 1998-08-15
DK0689609T3 (da) 1999-05-17
DE69412470D1 (de) 1998-09-17
ES2123775T5 (es) 2005-10-01
AU688307B2 (en) 1998-03-12

Similar Documents

Publication Publication Date Title
BR9508101A (pt) Detecção identificação e diferenciação simultánea de taxa eubacterial usando um ensaio de hibridização
DK0771360T3 (da) Fremgangsmåde til påvisning af antibiotikaresistensspektret for Mycobacteriumarter
CA2319662A1 (en) Modified nucleic acid probes and uses thereof
ES2123775T3 (es) Procedimiento para la tipificacion de hla-b por medio de iniciadores especificos y conjuntos de sondas.
ATE194391T1 (de) Amplifikationsoligonukleotide und sonden für borrelia, die mit lyme kranheit assoziiert sind
CA2525413A1 (en) Compositions, methods and kits for determining the presence of trichomonas vaginalis in a test sample
ES2096041T3 (es) Deteccion de secuencias nucleotidicas complementarias.
CA2422956A1 (en) Compositions and methods for detecting human immunodeficiency virus 2 (hiv-2)
CA2366374A1 (en) Method for the detection and/or analysis, by means of primer extension techniques, of single nucleotide polymorphisms in restriction fragments, in particular in amplified restriction fragments generated using aflp
EP2302075A3 (en) Method for typing of HLA alleles
ATE184055T1 (de) Verfahren zum sensitiven nachweis von reverser transcriptase
WO2002029085A3 (en) Nucleotide detection method
AU4766000A (en) Method for analysing a patient's genetic predisposition to at least a disease and amplification adapted to such a method
ATE207544T1 (de) Amplikationsprimern und nukleinsäuresonden zum nachweis von coccidioides immites
ATE527376T1 (de) Pna-sonden, sondensätze, verfahren und kits im zusammenhang mit dem nachweis von candida
DE69636917D1 (de) Nucleinsäuresonden und Amplifizierungsoligonukleotide für Neisseria Spezies
DK0966545T3 (da) Fremgangsmåde til typebestemmelse af minor histokompatibilitetsantigen HA-1
WO2003054224A3 (de) Verfahren und integrierte vorrichtung zum nachweis von cytosinmethylierungen
Capper et al. A chemiluminescent technique for detection of HLA polymorphism using PCR amplification and sequence specific oligonucleotide hybridization
CA2211165A1 (en) Methods for sensitive detection of reverse transcriptase

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 689609

Country of ref document: ES